Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RETINOL vs REVUMENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RETINOL vs REVUMENIB: Safety Overview

Metric RETINOL REVUMENIB
Total FAERS Reports 296 371
Deaths Reported 58 49
Death Rate 19.6% 13.2%
Hospitalizations 198 93
Average Patient Age 56.3 yrs 46.4 yrs
% Female Patients 91.8% 47.6%
FDA Approval Date N/A Nov 15, 2024
Manufacturer HYDRASPHERE PLUS LLC Syndax Pharmaceuticals, Inc.
Route CUTANEOUS ORAL
Marketing Status N/A Prescription